{"id":"NCT02370251","sponsor":"University of Oklahoma","briefTitle":"Compassionate Use of Omegaven in Children","officialTitle":"Fish Oil Lipid Emulsion for the Treatment of Parenteral-Nutrition-Associated Liver Disease in Infants","status":"COMPLETED","phase":"PHASE2","dates":{"start":"2015-06","primaryCompletion":"2018-09-27","completion":"2019-09-27","firstPosted":"2015-02-24","resultsPosted":"2019-11-25","lastUpdate":"2019-11-25"},"enrollment":63,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Total Parenteral Nutrition-induced Cholestasis","Cholestasis","Short Bowel Syndrome","Gastroschisis","Intestinal Atresia","Infant, Premature, Diseases","Cholestasis of Parenteral Nutrition"],"interventions":[{"type":"DRUG","name":"Omegaven","otherNames":["Fish oil-based lipid","Omega-3-fatty acid lipid emulsion"]}],"arms":[{"label":"Omegaven","type":"EXPERIMENTAL"}],"summary":"This is a single-assignment study to evaluate whether Omegaven (IV fish oil) is effective at treating liver disease in children on long-term IV nutrition.","primaryOutcome":{"measure":"Resolution of Cholestasis for Subjects Who Received Omegaven","timeFrame":"Within the first 3 months of sole Omegaven use","effectByArm":[{"arm":"Omegaven","deltaMin":40,"sd":null}],"pValues":[]},"eligibility":{"minAge":null,"sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":4},"locations":{"siteCount":1,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":9,"n":52},"commonTop":[]}}